vs
STANDARD BIOTOOLS INC.（LAB）与Ponce Financial Group, Inc.（PDLB）财务数据对比。点击上方公司名可切换其他公司
Ponce Financial Group, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.6倍（$31.4M vs $19.6M），Ponce Financial Group, Inc.净利率更高（36.3% vs -177.4%，领先213.7%），Ponce Financial Group, Inc.同比增速更快（37.6% vs -11.5%），Ponce Financial Group, Inc.自由现金流更多（$54.6M vs $-23.1M），过去两年Ponce Financial Group, Inc.的营收复合增速更高（23.7% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
庞塞金融集团是总部位于美国的金融控股公司，核心子公司为庞塞银行，主要服务纽约大都会区的多元文化、移民及中低收入社区，提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
LAB vs PDLB — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $31.4M |
| 净利润 | $-34.7M | $10.1M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 43.6% |
| 净利率 | -177.4% | 36.3% |
| 营收同比 | -11.5% | 37.6% |
| 净利润同比 | -28.8% | 245.6% |
| 每股收益（稀释后） | $-0.09 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $31.4M | ||
| Q3 25 | $19.6M | $26.7M | ||
| Q2 25 | $21.8M | $26.5M | ||
| Q1 25 | $40.8M | $24.6M | ||
| Q4 24 | — | $22.8M | ||
| Q3 24 | $22.1M | $20.2M | ||
| Q2 24 | $22.5M | $20.2M | ||
| Q1 24 | $45.5M | $20.5M |
| Q4 25 | — | $10.1M | ||
| Q3 25 | $-34.7M | $6.5M | ||
| Q2 25 | $-33.5M | $6.1M | ||
| Q1 25 | $-26.0M | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | $-26.9M | $2.4M | ||
| Q2 24 | $-45.7M | $3.2M | ||
| Q1 24 | $-32.2M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 43.6% | ||
| Q3 25 | -168.5% | 32.8% | ||
| Q2 25 | -118.1% | 30.2% | ||
| Q1 25 | -80.8% | 32.5% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | -120.9% | 15.2% | ||
| Q2 24 | -134.5% | 21.8% | ||
| Q1 24 | -132.2% | 18.3% |
| Q4 25 | — | 36.3% | ||
| Q3 25 | -177.4% | 24.3% | ||
| Q2 25 | -153.7% | 23.0% | ||
| Q1 25 | -63.8% | 24.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | -122.0% | 12.1% | ||
| Q2 24 | -203.3% | 15.8% | ||
| Q1 24 | -70.6% | 11.8% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-0.09 | $0.27 | ||
| Q2 25 | $-0.09 | $0.25 | ||
| Q1 25 | $-0.07 | $0.25 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | $-0.07 | $0.10 | ||
| Q2 24 | $-0.12 | $0.14 | ||
| Q1 24 | $-0.27 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $126.2M |
| 总债务越低越好 | — | $596.1M |
| 股东权益账面价值 | $399.7M | $541.5M |
| 总资产 | $539.6M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势，按日历期对齐
| Q4 25 | — | $126.2M | ||
| Q3 25 | $129.4M | $146.6M | ||
| Q2 25 | $158.6M | $126.6M | ||
| Q1 25 | $150.9M | $129.9M | ||
| Q4 24 | — | $139.8M | ||
| Q3 24 | $210.6M | $155.8M | ||
| Q2 24 | $269.8M | $103.2M | ||
| Q1 24 | $287.1M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | $55.2M | $580.4M | ||
| Q2 24 | $55.1M | $680.4M | ||
| Q1 24 | $55.0M | $680.4M |
| Q4 25 | — | $541.5M | ||
| Q3 25 | $399.7M | $529.8M | ||
| Q2 25 | $424.5M | $521.1M | ||
| Q1 25 | $454.6M | $513.9M | ||
| Q4 24 | — | $505.5M | ||
| Q3 24 | $489.3M | $504.6M | ||
| Q2 24 | $510.3M | $497.7M | ||
| Q1 24 | $577.3M | $493.7M |
| Q4 25 | — | $3.2B | ||
| Q3 25 | $539.6M | $3.2B | ||
| Q2 25 | $557.0M | $3.2B | ||
| Q1 25 | $579.6M | $3.1B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $681.5M | $3.0B | ||
| Q2 24 | $708.7M | $2.8B | ||
| Q1 24 | $777.7M | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | 0.11× | 1.15× | ||
| Q2 24 | 0.11× | 1.37× | ||
| Q1 24 | 0.10× | 1.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $55.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $54.6M |
| 自由现金流率自由现金流/营收 | -118.1% | 173.9% |
| 资本支出强度资本支出/营收 | 4.5% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 5.48× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $74.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $55.6M | ||
| Q3 25 | $-22.2M | $1.4M | ||
| Q2 25 | $-20.7M | $6.2M | ||
| Q1 25 | $-30.3M | $13.1M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-27.9M | $-14.6M | ||
| Q2 24 | $-39.0M | $-2.6M | ||
| Q1 24 | $-62.5M | $1.5M |
| Q4 25 | — | $54.6M | ||
| Q3 25 | $-23.1M | $786.0K | ||
| Q2 25 | $-22.6M | $5.9M | ||
| Q1 25 | $-35.3M | $12.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-30.1M | $-15.0M | ||
| Q2 24 | $-41.0M | $-2.6M | ||
| Q1 24 | $-63.3M | $-315.0K |
| Q4 25 | — | 173.9% | ||
| Q3 25 | -118.1% | 2.9% | ||
| Q2 25 | -103.6% | 22.4% | ||
| Q1 25 | -86.6% | 52.6% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | -136.4% | -74.1% | ||
| Q2 24 | -182.2% | -13.0% | ||
| Q1 24 | -138.9% | -1.5% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 4.5% | 2.3% | ||
| Q2 25 | 8.7% | 1.0% | ||
| Q1 25 | 12.4% | 0.6% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | 10.2% | 2.0% | ||
| Q2 24 | 8.6% | 0.3% | ||
| Q1 24 | 1.7% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PDLB
暂无分部数据
